Month: February 2022

The claim: Pfizer pulled all vaccine applications, Moderna’s CEO sold 90% of his shares and Johnson & Johnson halted vaccine production A widespread rumor circulating online attempts to cast doubt on Pfizer, Moderna and Johnson & Johnson – the companies that produce the three COVID-19 vaccines authorized in the U.S. “I am triple vaccinated more left than right on the political spectrum. Something is severely off with these Covid vaccines,” reads a Feb. 14 tweet that accumulated more than 37,000 likes within less than a week. “Pfitzer (sic) just pulled all remaining applications in 10 plus countries. Moderna CEO just sold 90% of his shares. Pfitzer (sic) is refusing to release info.” In a subsequent post, the Twitter user, Ron Dineen, also claimed Johnson & Johnson “halted all ...

The Food and Drug Administration (FDA) on Wednesday authorized the first-ever condom intended for safe anal intercourse. Authorization of the One Male Condom is expected to help reduce the transmission of sexually transmitted infections (STIs), including HIV/AIDS in both anal and vaginal intercourse, the FDA said in a press release. “The risk of STI transmission during anal intercourse is significantly higher than during vaginal intercourse. The FDA’s authorization of a condom that is specifically indicated, evaluated and labeled for anal intercourse may improve the likelihood of condom use during anal intercourse,” said Courtney Lias, the director of the FDA’s Office of GastroRenal, ObGyn, General Hospital, and Urology Devices in the Center for Devices and Radiological Health. ...

"));var p=b(h[i.size_id].split("x").map(function(e){return Number(e)}),2);f.width=p[0],f.height=p[1]}f.rubiconTargeting=(Array.isArray(i.targeting)?i.targeting:[]).reduce(function(e,t){return e[t.key]=t.values[0],e},{rpfl_elemid:l.adUnitCode}),t.push(f)}else Object(r.logError)("Rubicon: bidRequest undefined at index position:".concat(o),n,e);return t},[]).sort(function(e,t){return(t.cpm||0)-(e.cpm||0)})},getUserSyncs:function(e,t,n,r){if(!U&&e.iframeEnabled){var i="";return n&&"string"==typeof n.consentString&&("boolean"==typeof n.gdprApplies?i+="?gdpr=".concat(Number(n.gdprApplies),"&gdpr_consent=").concat(n.consentString):i+="?gdpr_consent=".concat(n.consentString)),r&&(i+="".concat(i?"&":"?","us_privacy=").concat(encodeURIComponent(r))),U=!0,{type...

Around January, a disconcerting trend was emerging in the Hackensack Meridian hospital system. Many of the patients and staff who tested positive for the coronavirus were fully vaccinated — they had received their primary shots, plus if they were eligible, the booster. The common thread? They were more than four months out from their last primary vaccine series or booster. “We saw this a lot,” said Dr. Daniel Varga, the chief physician executive of Hackensack Meridian Health, one of the state’s largest hospital systems. “Breakthrough infections that we saw virtually never happen in the first four months after somebody either completed their primary immunization series or got their booster. “So [for] the first four months, we had virtually zero breakthrough cases. Then in the fifth mon...

But at the height of the pandemic, many patients couldn't get the treatment because there weren't enough beds, machines or skilled staff to care for them, the study found. Nearly 90% of patients who met Vanderbilt's stringent criteria to receive ECMO, but couldn't get in for care, died. "I think this is very powerful to me, because, you know, for the first time, we were actually seeing what is happening to these patients, when they don't receive this therapy," said lead study researcher Whitney Gannon, director of quality and education for the adult ECMO program at Vanderbilt. Gannon said when the Delta surge was at its worst in the South, she would get 10 to 15 calls a day for patients who needed ECMO. At maximum capacity, Vanderbilt had space for seven EMCO patients at a time, so many of...